Cargando…
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Alzheimer-type dementia (ATD) treatments face limitations in crossing the blood–brain barrier and systemic adverse effects. Intranasal administration offers a direct route to the brain via the nasal cavity’s olfactory and trigeminal pathways. However, nasal physiology can hinder drug absorption and...
Autores principales: | Taléns-Visconti, Raquel, de Julián-Ortiz, Jesus Vicente, Vila-Busó, Ofelia, Diez-Sales, Octavio, Nácher, Amparo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223127/ https://www.ncbi.nlm.nih.gov/pubmed/37242641 http://dx.doi.org/10.3390/pharmaceutics15051399 |
Ejemplares similares
-
Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials
por: Taléns-Visconti, Raquel, et al.
Publicado: (2022) -
New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases
por: Taléns-Visconti, Raquel, et al.
Publicado: (2022) -
Intranasal administration of acetylcholinesterase inhibitors
por: Costantino, Henry R, et al.
Publicado: (2008) -
Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease
por: Wang, Kaixuan, et al.
Publicado: (2021) -
Intranasal Insulin for Alzheimer’s Disease
por: Hallschmid, Manfred
Publicado: (2021)